Overview
Voravit Ratanatharathorn is a Hematologist Oncology specialist and a Hematologist in Detroit, Michigan. Dr. Ratanatharathorn has been practicing medicine for over 49 years and is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Multiple Myeloma, Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), and Bone Marrow Transplant. Dr. Ratanatharathorn is currently accepting new patients.
His clinical research consists of co-authoring 54 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 25 articles in the study of Graft Versus Host Disease (GvHD).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
University Physician Group
Joseph Uberti is a Hematologist Oncology specialist and an Oncologist in Detroit, Michigan. Dr. Uberti is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Graft Versus Host Disease (GvHD), Multiple Myeloma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, and Bone Marrow Transplant. Dr. Uberti is currently accepting new patients.
Vedran Radojcic is a Hematologist Oncology provider in Ann Arbor, Michigan. Dr. Radojcic is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.
University Physician Group
Lois Ayash is a Hematologist Oncology specialist and a Hematologist in Detroit, Michigan. Dr. Ayash is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). Her top areas of expertise are Graft Versus Host Disease (GvHD), Multiple Myeloma, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Ayash is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bone Marrow TransplantDr. Ratanatharathorn isElite. Learn about Bone Marrow Transplant.
- Distinguished
- Acute Myeloblastic Leukemia without MaturationDr. Ratanatharathorn isDistinguished. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Ratanatharathorn isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Graft Versus Host Disease (GvHD)Dr. Ratanatharathorn isDistinguished. Learn about Graft Versus Host Disease (GvHD).
- Multiple MyelomaDr. Ratanatharathorn isDistinguished. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Ratanatharathorn isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Ratanatharathorn isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Megakaryoblastic LeukemiaDr. Ratanatharathorn isAdvanced. Learn about Acute Megakaryoblastic Leukemia.
- Acute Myeloblastic Leukemia with MaturationDr. Ratanatharathorn isAdvanced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myelomonocytic LeukemiaDr. Ratanatharathorn isAdvanced. Learn about Acute Myelomonocytic Leukemia.
- Childhood Acute Myeloid LeukemiaDr. Ratanatharathorn isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelogenous Leukemia (CML)Dr. Ratanatharathorn isAdvanced. Learn about Chronic Myelogenous Leukemia (CML).
- Experienced
- Adult T-Cell LeukemiaDr. Ratanatharathorn isExperienced. Learn about Adult T-Cell Leukemia.
- Anaplastic Large Cell LymphomaDr. Ratanatharathorn isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaDr. Ratanatharathorn isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Aplastic AnemiaDr. Ratanatharathorn isExperienced. Learn about Aplastic Anemia.
- B-Cell LymphomaDr. Ratanatharathorn isExperienced. Learn about B-Cell Lymphoma.
- Breast CancerDr. Ratanatharathorn isExperienced. Learn about Breast Cancer.